Stay updated on IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial
Sign up to get notified when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.

Latest updates to the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new version entry (2024-11-14) was added to the record history, documenting updates to Recruitment Status and Study Status.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check42 days agoChange DetectedSummary: The page adds a government-operating-status notice and a v3.2.0 release tag, while removing the v3.1.0 tag. The new notice is the significant change, signaling updated operating status and potential transaction delays.SummaryDifference12%

- Check49 days agoChange DetectedUpdate the page version from v3.0.2 to v3.1.0, reflecting a newer release metadata.SummaryDifference0.3%

- Check64 days agoChange DetectedVersion bump from v3.0.1 to v3.0.2; removal of the Back to Top element; overall change is minor and mainly metadata/UI cleanup.SummaryDifference0.7%

- Check71 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.SummaryDifference0.7%

- Check78 days agoChange DetectedThe web page has undergone significant changes, including the addition of a facility name and location details, while several location-related terms have been removed.SummaryDifference9%

Stay in the know with updates to IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the IBI310 + Sintilimab in dMMR/MSI-H CRC Clinical Trial page.